Delivery Order 36C26323D0087-36C26326N0391
- Not listed
- The Department of Veterans Affairs, Veterans Integrated Service Network 23 (VISN 23), awarded a delivery order valued at $168,000 to Veracyte, Inc. for reference laboratory services with a completion date of April 30, 2026. This task order was issued under an existing Indefinite Delivery/Indefinite Quantity (IDIQ) contract for Veracyte Reference Laboratory Services with VISN 23, which carries a total ceiling value of $2 million through April 2028. The contract utilizes firm fixed pricing and was...
- The Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 23, awarded a $112,200 firm fixed-price delivery order to Veracyte, Inc., a South San Francisco-based medical diagnostic company specializing in advanced genomic testing services. The task order, effective May 1, 2026, with an ultimate completion date of April 30, 2027, will be performed at Veracyte's headquarters location in South San Francisco, California. This delivery order was issued without a small business...
- The Department of Veterans Affairs, Veterans Integrated Service Network 8 (VISN 8), awarded a delivery order valued at $96,960 to Veracyte, Inc. for gene testing services. The award, issued on February 5, 2026, is a firm fixed-price delivery order with an ultimate completion date of February 4, 2027, and carries no small business set-aside designation. The contract will be performed in South San Francisco, California, where Veracyte maintains its headquarters. This delivery order is issued under...
- The Department of Veterans Affairs, Veterans Integrated Service Network 23 (VISN 23), awarded a delivery order to Veracyte, Inc. for reference laboratory services under an Indefinite Delivery/Indefinite Quantity (IDIQ) contract. The award, issued on May 1, 2024, carries a ceiling value of $11.2K and an ultimate completion date of April 30, 2025. Veracyte, Inc., a South San Francisco-based medical diagnostic company specializing in advanced genomic testing, will deliver molecular and genomic...
- The Department of Veterans Affairs, Veterans Integrated Service Network 23 (VISN 23), awarded a $67.6K delivery order to Veracyte, Inc. on May 1, 2026, for reference laboratory and genomic testing services supporting the NWI-Omaha VA facility. The order is structured as a firm fixed-price delivery order with a completion deadline of September 30, 2026, and carries no small business set-aside designation. This award is issued under Veracyte's existing $2M indefinite delivery/indefinite quantity...
- Veracyte, Inc. was awarded a $451.2K firm fixed-price purchase order by Veterans Integrated Service Network 17 (VISN 17), a civilian component of the Department of Veterans Affairs, for genomic laboratory testing services. The contract was awarded on August 15, 2022, with an ultimate completion date of August 14, 2027, and will be performed in Dallas, Texas. This award carries no small business set-aside designation and represents a continuation of Veracyte's established relationship with the...
- The Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 23, awarded a delivery order valued at $85,000 to Veracyte, Inc. for Afirma thyroid testing services supporting the Fargo VA Health Care System. This firm fixed-price delivery order, issued on May 1, 2026, is scheduled for completion by April 30, 2027. The award carries no small business set-aside designation and reflects the proprietary and specialized nature of Veracyte's genomic diagnostic capabilities. The work...
- Veracyte, Inc. received a delivery order valued at $42,000 from Veterans Integrated Service Network (VISN) 23 for reference laboratory services, with an ultimate completion date of April 30, 2026. This firm fixed-price delivery order, awarded on May 1, 2025, carries no small business set-aside designation and represents work to be performed at Veracyte's headquarters facility in South San Francisco, California. The delivery order was issued to de-obligate excess fiscal year 2025 funds under...
- This federal contract award is for a task order under the NWI VAHCS TASK ORDER VERACYTE REFERENCE LABORATORY SERVICES IDIQ, a $62,000.00 firm fixed-price delivery order contract awarded to Veracyte, Inc., a for-profit medical diagnostic company headquartered in South San Francisco, California. The contract is with the Veterans Integrated Service Network 23 (VISN 23), a civilian agency under the Department of Veterans Affairs, for reference laboratory services. Veracyte will provide specialized...
- This federal contract award is for thyroid biopsy lab testing services for the Veterans Integrated Service Network 23 (VISN 23) medical centers, specifically the Minneapolis VA Health Care System. The contract was awarded to Veracyte, Inc., a for-profit company that provides genomic testing services, and is a Delivery Order under an existing Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle with a potential value of $600,000 through April 2028. The award has a ceiling value of...
- 36C26323D0087Indefinite Delivery Contract
- 36C26323D0087-36C26326N0391Delivery Order
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 23, awarded a $168,000 firm fixed-price delivery order to Veracyte, Inc. on May 1, 2026, to support genomic testing services at the Minneapolis VA facility through April 30, 2027. This task order was issued under Veracyte's existing $2 million indefinite delivery/indefinite quantity contract with VISN 23 for reference laboratory services, which runs through April 30, 2028. The award carries no small business set-aside designation and reflects the specialized nature of Veracyte's proprietary diagnostic capabilities. Work will be performed at the contractor's facility in South San Francisco, California. Veracyte is a medical diagnostic company specializing in advanced genomic testing services for precision medicine applications, with a well-established track record serving the VA, Defense Health Agency, and Indian Health Service. The company's core diagnostic offerings include the Decipher Prostate Cancer Test for assessing metastatic potential and the Afirma Genomic Sequencing Classifier for thyroid nodule malignancy risk assessment. The Minneapolis VA delivery order represents one of multiple task orders Veracyte has received across various Veterans Integrated Service Networks to support the VA's precision medicine and personalized cancer care initiatives through genomic molecular testing services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $168.0k | 2/24/26 |